[1] F. Liu, M. Korc, Cdk4/6 inhibition induces epithelial-mesenchymal transition and enhances invasiveness in pancreatic cancer cells, Mol Cancer Ther 11 (2012) 2138-2148.
[2] N.A. Schultz, C. Dehlendorff, B.V. Jensen, J.K. Bjerregaard, K.R. Nielsen, S.E. Bojesen, D. Calatayud, S.E. Nielsen, M. Yilmaz, N.H. Hollander, K.K. Andersen, J.S. Johansen, MicroRNA biomarkers in whole blood for detection of pancreatic cancer, Jama 311 (2014) 392-404.
[3] A. Pandita, S. Manvati, S.K. Singh, S. Vaishnavi, R.N. Bamezai, Combined effect of microRNA, nutraceuticals and drug on pancreatic cancer cell lines, Chem Biol Interact 233 (2015) 56-64.
[4] Y. Shao, M. Ye, Q. Li, W. Sun, G. Ye, X. Zhang, Y. Yang, B. Xiao, J. Guo, LncRNA-RMRP promotes carcinogenesis by acting as a miR-206 sponge and is used as a novel biomarker for gastric cancer, Oncotarget (2016).
[5] X. Zhou, H. Chen, L. Zhu, B. Hao, W. Zhang, J. Hua, H. Gu, W. Jin, G. Zhang, Helicobacter pylori infection related long noncoding RNA (lncRNA) AF147447 inhibits gastric cancer proliferation and invasion by targeting MUC2 and up-regulating miR-34c, Oncotarget 7 (2016) 82770-82782.
[6] H. Xia, Q. Chen, Y. Chen, X. Ge, W. Leng, Q. Tang, M. Ren, L. Chen, D. Yuan, Y. Zhang, M. Liu, Q. Gong, F. Bi, The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis, Oncotarget 7 (2016) 56209-56218.
[7] Y. Cui, F. Zhang, C. Zhu, L. Geng, T. Tian, H. Liu, Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/beta-catenin signaling pathway, Oncotarget 8 (2017) 17785-17794.
[8] H. Cai, J. Yao, Y. An, X. Chen, W. Chen, D. Wu, B. Luo, Y. Yang, Y. Jiang, D. Sun, X. He, LncRNA HOTAIR acts a competing endogenous RNA to control the expression of notch3 via sponging miR-613 in pancreatic cancer, Oncotarget (2017).
[9] H.W. Xie, Q.Q. Wu, B. Zhu, F.J. Chen, L. Ji, S.Q. Li, C.M. Wang, Y.S. Tong, L. Tuo, M. Wu, Z.H. Liu, J. Lv, W.H. Shi, X.F. Cao, Long noncoding RNA SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and associated with poor prognosis, Tumour Biol 35 (2014) 7743-7754.
[10] V. Mouraviev, B. Lee, V. Patel, D. Albala, T.E. Johansen, A. Partin, A. Ross, R.J. Perera, Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer, Prostate Cancer Prostatic Dis 19 (2016) 14-20.
[11] F. Shen, W.S. Cai, Z. Feng, J.W. Chen, J.H. Feng, Q.C. Liu, Y.P. Fang, K.P. Li, H.Q. Xiao, J. Cao, B. Xu, Long non-coding RNA SPRY4-IT1 pormotes colorectal cancer metastasis by regulate epithelial-mesenchymal transition, Oncotarget (2016).
[12] J. Mazar, W. Zhao, A.M. Khalil, B. Lee, J. Shelley, S.S. Govindarajan, F. Yamamoto, M. Ratnam, M.N. Aftab, S. Collins, B.N. Finck, X. Han, J.S. Mattick, M.E. Dinger, R.J. Perera, The functional characterization of long noncoding RNA SPRY4-IT1 in human melanoma cells, Oncotarget 5 (2014) 8959-8969.
[13] X.L. Zhao, Z.H. Zhao, W.C. Xu, J.Q. Hou, X.Y. Du, Increased expression of SPRY4-IT1 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer, Int J Clin Exp Pathol 8 (2015) 1954-1960.
[14] Y. Zhou, D.L. Wang, Q. Pang, Long noncoding RNA SPRY4-IT1 is a prognostic factor for poor overall survival and has an oncogenic role in glioma, Eur Rev Med Pharmacol Sci 20 (2016) 3035-3039.
[15] D. Khaitan, M.E. Dinger, J. Mazar, J. Crawford, M.A. Smith, J.S. Mattick, R.J. Perera, The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion, Cancer Res 71 (2011) 3852-3862.
[16] D. Cao, Q. Ding, W. Yu, M. Gao, Y. Wang, Long noncoding RNA SPRY4-IT1 promotes malignant development of colorectal cancer by targeting epithelial-mesenchymal transition, Onco Targets Ther 9 (2016) 5417-5425.
[17] C.Y. Zhang, R.K. Li, Y. Qi, X.N. Li, Y. Yang, D.L. Liu, J. Zhao, D.Y. Zhu, K. Wu, X.D. Zhou, S. Zhao, Upregulation of long noncoding RNA SPRY4-IT1 promotes metastasis of esophageal squamous cell carcinoma via induction of epithelial-mesenchymal transition, Cell Biol Toxicol 32 (2016) 391-401.
[18] M. Sun, X.H. Liu, K.H. Lu, F.Q. Nie, R. Xia, R. Kong, J.S. Yang, T.P. Xu, Y.W. Liu, Y.F. Zou, B.B. Lu, R. Yin, E.B. Zhang, L. Xu, W. De, Z.X. Wang, EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition, Cell Death Dis 5 (2014) e1298.
[19] C.C. Liang, A.Y. Park, J.L. Guan, In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro, Nat Protoc 2 (2007) 329-333.
[20] C. Yu, M. Wang, Z. Li, J. Xiao, F. Peng, X. Guo, Y. Deng, J. Jiang, C. Sun, MicroRNA-138-5p regulates pancreatic cancer cell growth through targeting FOXC1, Cell Oncol (Dordr) 38 (2015) 173-181.
[21] S. Tian, X. Guo, C. Yu, C. Sun, J. Jiang, miR-138-5p suppresses autophagy in pancreatic cancer by targeting SIRT1, Oncotarget (2016).
[22] Y. Zhang, C. Lin, G. Liao, S. Liu, J. Ding, F. Tang, Z. Wang, X. Liang, B. Li, Y. Wei, Q. Huang, X. Li, B. Tang, MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2, Oncotarget 6 (2015) 32586-32601.
[23] P. Wang, Z. Li, H. Liu, D. Zhou, A. Fu, E. Zhang, MicroRNA-126 increases chemosensitivity in drug-resistant gastric cancer cells by targeting EZH2, Biochem Biophys Res Commun 479 (2016) 91-96.
[24] F. Zheng, Y.J. Liao, M.Y. Cai, Y.H. Liu, T.H. Liu, S.P. Chen, X.W. Bian, X.Y. Guan, M.C. Lin, Y.X. Zeng, H.F. Kung, D. Xie, The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2, Gut 61 (2012) 278-289.
[25] D. Liu, Y. Li, G. Luo, X. Xiao, D. Tao, X. Wu, M. Wang, C. Huang, L. Wang, F. Zeng, G. Jiang, LncRNA SPRY4-IT1 sponges miR-101-3p to promote proliferation and metastasis of bladder cancer cells through up-regulating EZH2, Cancer Lett 388 (2016) 281-291.
[26] M. Zhou, X.Y. Zhang, X. Yu, Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma, Biomed Pharmacother 85 (2017) 348-354.
[27] P. Chen, D. Wan, D. Zheng, Q. Zheng, F. Wu, Q. Zhi, Long non-coding RNA UCA1 promotes the tumorigenesis in pancreatic cancer, Biomed Pharmacother 83 (2016) 1220-1226.
[28] W. Peng, A. Jiang, Long noncoding RNA CCDC26 as a potential predictor biomarker contributes to tumorigenesis in pancreatic cancer, Biomed Pharmacother 83 (2016) 712-717.
[29] H.X. Zhan, Y. Wang, C. Li, J.W. Xu, B. Zhou, J.K. Zhu, H.F. Han, L. Wang, Y.S. Wang, S.Y. Hu, LincRNA-ROR promotes invasion, metastasis and tumor growth in pancreatic cancer through activating ZEB1 pathway, Cancer Lett 374 (2016) 261-271.
[30] M. Xie, F.Q. Nie, M. Sun, R. Xia, Y.W. Liu, P. Zhou, W. De, X.H. Liu, Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition, J Transl Med 13 (2015) 250.
[31] J. Xue-Liang, W. Ming-Dong, Z. Ya-Bi, W. Wang-Yue, Upregulated long noncoding RNA SPRY4-IT1 contributes to increased cell viability by activating zinc finger 703 expression in esophageal squamous cell carcinoma, Indian J Cancer 52 Suppl 3 (2015) E164-167.
[32] Y. Mei, J. Si, Y. Wang, Z. Huang, H. Zhu, S. Feng, X. Wu, L. Wu, Long noncoding RNA GAS5 suppresses tumorigenesis by inhibiting miR-23a 5 expression in non-small cell lung cancer, Oncol Res (2017).
[33] X.B. Zhao, G.S. Ren, LncRNA Taurine-Upregulated Gene 1 Promotes Cell Proliferation by Inhibiting MicroRNA-9 in MCF-7 Cells, J Breast Cancer 19 (2016) 349-357.